Filing Details
- Accession Number:
- 0001140361-22-036652
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-10-07 16:32:04
- Reporting Period:
- 2022-10-06
- Accepted Time:
- 2022-10-07 16:32:04
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1764013 | Immunovant Inc. | IMVT | Pharmaceutical Preparations (2834) | D0 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1635088 | Ltd. Sciences Roivant | Suite 1, 3Rd Floor 11-12 St. James'S Square London X0 SW1Y 4LB | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.0001 Par Value Per Share | Acquisiton | 2022-10-06 | 416,667 | $6.00 | 73,805,331 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
